High angiotensin II responsiveness is associated with decreased endothelium-dependent relaxation in human arteries

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 6, Issue 3, 2005, Pages 145-150

  Voors, Adriaan A ^a   van Geel, Peter Paul ^a   Buikema, Hendrik ^a   Oosterga, Margreeth ^a   van Veldhuisen, Dirk J ^a   van Gilst, Wiek H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ACE inhibition; Angiotensin II; Endothelial dysfunction; Human arteries

Indexed keywords

ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHACHOLINE; NITRIC OXIDE; PHENYLEPHRINE; PLACEBO; QUINAPRIL;

ADULT; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; ISOLATED ARTERY; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; TREATMENT DURATION;

ANGIOTENSIN II; ARTERIES; CORONARY ARTERY BYPASS; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; FEMALE; HUMANS; MALE; MAMMARY ARTERIES; METHACHOLINE CHLORIDE; MIDDLE AGED; VASOCONSTRICTION; VASODILATION;

EID: 33144469312     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2005.021     Document Type: Article

References (29)

1. Weber KT. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation 1997;96:4065-82.
2. Raij L. Workshop: hypertension and cardiovascular risk factors: role of the angiotensin II-nitric oxide interaction. Hypertension 2001;37(2 Part 2):767-73.
3. Romero JC, Reckelhoff JF. State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 1999;34(4 Pt 2):943-9.
4. Nickenig G, Strehlow K, Roeling J, Zolk O, Knorr A, Bohm M. Salt induces vascular AT1-receptor over expression in vitro and in vivo. Hypertension 1998;31:1272-7.
5. 1-receptor gene expression by posttranscriptional mechanisms. Circulation 1998;98:2453-60.
6. Nickenig G, Baumer AT, Temur Y, Kebben D, Jockenhovel F, Bohm M. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. Circulation 1999;100:2131-4.
7. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-8.
8. Rajagopalan S, Kurz S, Munzel T et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916-23.
9. Ishizaka N, Griendling KK, Lassegue B, Alexander RW. Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 1998;32:459-66.
10. Guan H, Cachofeiro V, Pucci ML, Kaminski PM, Wolin MS, Nasjletti A. Nitric oxide and the depressor response to angiotensin blockade in hypertension. Hypertension 1996;27(1):19-24.
11. Takemoto M, Egashira K, Usui M et al. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 1997;99:278-87.
12. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 1993;21:660-6.
13. Oosterga M, Voors AA, Buikema H et al. Angiotensin II formation in human vasculature after chronic ACE inhibition: a prospective, randomized, placebo-controlled study. QUO VADIS Investigators. Cardiovasc Drugs Ther 2000;14(1):55-60.
14. Oosterga M, Voors AA, Pinto YM et al. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia. Am J Cardiol 2001;87:542-6.
15. Buikema H, Grandjean JG, van den Brock S, van Gilst WH, Lie KI, Wesseling H. Differences in vasomotor control between human gastroepiploic and left internal mammary artery. Circulation 1992;86:II205-II209.
16. Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 1971;20:1637-48.
17. Yang BC, Phillips MI, Mohuczy D et al. Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1998;18:1433-9.
18. Gunther S, Gimbrone MA, Jr., Alexander RW. Regulation by angiotensin II of its receptors in resistance blood vessels. Nature 1980;287:230-2.
19. Kitamoto S, Egashira K, Kataoka C et al. Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. J Hypertens 2000;18:1795-800.
20. Ichiki T, Usui M, Kato M et al. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 1998;31(1 Pt 2):342-8.
21. Usui M, Ichiki T, Katoh M, Egashira K, Takeshita A. Regulation of angiotensin II receptor expression by nitric oxide in rat adrenal gland. Hypertension 1998;32:527-33.
22. Martin W, Furchgott RF, Villani GM, Jothianandan D. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. J Pharmacol Exp Ther 1986;237:529-38.
23. Bullock GR, Taylor SG, Weston AH. Influence of the vascular endothelium on agonist-induced contractions and relaxations in rat aorta. Br J Pharmacol 1986;89:819-30.
24. Rees DD, Palmer RM, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989;96:418-24.
25. Hornig B, Arakawa N, Haussmann D, Drexler H. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998;98:2842-8.
26. Stephens N, Drinkhill MJ, Hall AS, Ball SG, Heagerty AM. Structure and in vitro function of human subcutaneous small arteries in mild heart failure. Am J Physiol 1998;274(5 Pt 1): C1298-C1305.
27. Mancini GB, Henry GC, Macaya C et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) study. Circulation 1996;94:258-64.
28. Prasad A, Husain S, Quyyumi AA. Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin. J Am Coll Cardiol 1999;33:796-804.
29. van der Harst P, Volbeda M, Voors AA et al. Vascular response to angiotensin II predicts long-term prognosis in patients undergoing coronary artery bypass grafting. Hypertension 2004;44:930-4.